FdaApplication
NDA 214952
Identifiers
- fda_app_no: NDA214952
Properties
| Property | Value |
|---|---|
| applicant_name | CMP DEVELOPMENT LLC |
| application_type | NDA |
| approval_date | 2023-04-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LIQREV | SILDENAFIL CITRATE | EQ 10MG BASE/ML | SUSPENSION;ORAL |
1 product